US President Trump’s proposed tariffs on pharmaceutical imports, potentially reaching 200%, aim to lower drug costs but could backfire. Experts warn of increased prices, supply chain disruptions, and reduced access to affordable generics.
The Headlines – Latest Business News Today: Stock Markets, Financial News, India Business & World Business News – Read More



